These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3942500)

  • 1. Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection.
    Dunn DL; Ewald DC; Chandan N; Cerra FB
    Arch Surg; 1986 Jan; 121(1):58-62. PubMed ID: 3942500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.
    Dunn DL; Bogard WC; Cerra FB
    Surgery; 1985 Aug; 98(2):283-90. PubMed ID: 3895540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced survival during murine gram-negative bacterial sepsis by use of a murine monoclonal antibody.
    Dunn DL; Bogard WC; Cerra FB
    Arch Surg; 1985 Jan; 120(1):50-3. PubMed ID: 3917664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
    Dunn DL; Mach PA; Condie RM; Cerra FB
    Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental gram-negative bacterial sepsis with murine monoclonal antibodies directed against lipopolysaccharide.
    Priest BP; Brinson DN; Schroeder DA; Dunn DL
    Surgery; 1989 Aug; 106(2):147-54; discussion 154-5. PubMed ID: 2763023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
    Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
    J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.
    Bogard WC; Dunn DL; Abernethy K; Kilgarriff C; Kung PC
    Infect Immun; 1987 Apr; 55(4):899-908. PubMed ID: 3549565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.
    Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM
    J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
    Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
    J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species.
    Mutharia LM; Crockford G; Bogard WC; Hancock RE
    Infect Immun; 1984 Sep; 45(3):631-6. PubMed ID: 6381310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody immunotherapy of gram-negative bacterial sepsis in an immunosuppressed animal model.
    Dunn DL
    Transplantation; 1988 Feb; 45(2):424-9. PubMed ID: 3278438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.
    Di Padova FE; Brade H; Barclay GR; Poxton IR; Liehl E; Schuetze E; Kocher HP; Ramsay G; Schreier MH; McClelland DB
    Infect Immun; 1993 Sep; 61(9):3863-72. PubMed ID: 8359907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of monoclonal antibody E5 with endotoxin. II. Binding to short- and long-chain smooth lipopolysaccharides.
    Parent JB; Gazzano-Santoro H; Wood DM; Lim E; Pruyne PT; Trown PW; Conlon PJ
    Circ Shock; 1992 Sep; 38(1):63-73. PubMed ID: 1382882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide epitope specificity and binding cross reactivity of the human IgM anti-lipid A monoclonal antibody SdJ5-1.17.15.
    Kazemi M; Huntenburg CC; Bubbers JE
    Mol Immunol; 1993 Jul; 30(10):895-902. PubMed ID: 7688072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.
    Fink MP
    Crit Care Med; 1993 Feb; 21(2 Suppl):S32-9. PubMed ID: 8428494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of heparin in guinea pig gram negative bacterial sepsis.
    Dunn DL; Mach PA; Cerra FB; Ferguson RM
    J Surg Res; 1983 May; 34(5):479-85. PubMed ID: 6405100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive murine monoclonal antibodies directed against the core/lipid A region of endotoxin inhibit production of tumor necrosis factor.
    Mayoral JL; Dunn DL
    J Surg Res; 1990 Oct; 49(4):287-92. PubMed ID: 1699085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective capacity of polyclonal and monoclonal antibodies directed against endotoxin during experimental sepsis.
    Dunn DL; Priest BP; Condie RM
    Arch Surg; 1988 Nov; 123(11):1389-93. PubMed ID: 3178488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.